프로바이오틱스(Lactiplantibacillus plantarum KC3)·익모초추출복합물(CKDB-315)
프로바이오틱스(Lactiplantibacillus plantarum KC3)·익모초추출복합물(CKDB-315)
MFDS recognition no.
2025-1
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
980.0–980.0 mg/일
Approval holder
(주)종근당바이오
Approved wording (Korean original)
호흡기(기관∙기관지) 건강에 도움을 줄 수 있음
Precautions (Korean original)
(가) 질환이 있거나 의약품 복용 시 전문가와 상담할 것, (나) 특정 질환(단장 증후군, 알레르기 체질 등)이 있는 분은 섭취에 주의할 것, (다) 어린이가 함부로 섭취하지 않도록 일일섭취량 방법을 지도할 것, (라) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것, (마) 영·유아, 어린이, 임산부 및 수유부는 섭취를 피할 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.
Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.